nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—KRT19—bile duct cancer	0.0738	0.0775	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—ERBB2—bile duct cancer	0.0582	0.061	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—SOX17—bile duct cancer	0.0387	0.0406	CbGpPWpGaD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—bile duct cancer	0.0319	0.0335	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—EGFR—bile duct cancer	0.0294	0.0308	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—HRAS—bile duct cancer	0.0281	0.0295	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—GNAS—bile duct cancer	0.0278	0.0292	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—NOS2—bile duct cancer	0.0197	0.42	CrCbGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HGF—bile duct cancer	0.0191	0.0201	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB2—bile duct cancer	0.018	0.0189	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—SMAD4—bile duct cancer	0.0165	0.0174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	0.0145	0.0152	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TGFB1—bile duct cancer	0.0144	0.0151	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—NRAS—bile duct cancer	0.0137	0.0143	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—bile duct cancer	0.0129	0.0136	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—bile duct cancer	0.0125	0.0131	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—SMAD4—bile duct cancer	0.012	0.0126	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SMAD4—bile duct cancer	0.012	0.0126	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—bile duct cancer	0.0119	0.253	CrCbGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—KRAS—bile duct cancer	0.0118	0.0123	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—SMAD4—bile duct cancer	0.0113	0.0119	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bile duct cancer	0.011	0.0115	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—bile duct cancer	0.0108	0.0114	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MMP2—bile duct cancer	0.0108	0.0113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bile duct cancer	0.0107	0.0112	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—HRAS—bile duct cancer	0.01	0.0105	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD4—bile duct cancer	0.00997	0.0105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—bile duct cancer	0.00982	0.0103	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—bile duct cancer	0.00974	0.207	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—RNF43—bile duct cancer	0.00961	0.0101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—bile duct cancer	0.00957	0.01	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—NOS2—bile duct cancer	0.00956	0.01	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—HRAS—bile duct cancer	0.0087	0.00912	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00858	0.00901	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—NRAS—bile duct cancer	0.00838	0.0088	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bile duct cancer	0.00835	0.00876	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TGFBR2—bile duct cancer	0.00831	0.00872	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—bile duct cancer	0.00831	0.00872	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bile duct cancer	0.00825	0.00866	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MMP2—bile duct cancer	0.00821	0.00861	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—SMAD4—bile duct cancer	0.00787	0.00825	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NRAS—bile duct cancer	0.00732	0.00768	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.00722	0.00757	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00668	0.00701	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00652	0.00684	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bile duct cancer	0.0064	0.00672	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	0.00636	0.00667	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—KRAS—bile duct cancer	0.0063	0.00661	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bile duct cancer	0.00628	0.00659	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HGF—bile duct cancer	0.00624	0.00655	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—bile duct cancer	0.00613	0.00644	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00608	0.00638	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—SMAD4—bile duct cancer	0.00606	0.00636	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—bile duct cancer	0.00594	0.00623	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—bile duct cancer	0.00587	0.00616	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00575	0.00603	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—bile duct cancer	0.00567	0.12	CrCbGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—bile duct cancer	0.00539	0.00566	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP9—bile duct cancer	0.00538	0.00565	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	0.00536	0.00562	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP9—bile duct cancer	0.0053	0.00556	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00502	0.00527	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00488	0.00513	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—bile duct cancer	0.00466	0.00489	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—bile duct cancer	0.00454	0.00476	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—bile duct cancer	0.00447	0.00469	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—bile duct cancer	0.00445	0.00467	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—bile duct cancer	0.00443	0.00465	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFBR2—bile duct cancer	0.00439	0.00461	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—bile duct cancer	0.00437	0.00458	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GNAS—bile duct cancer	0.00424	0.00445	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SMAD4—bile duct cancer	0.00416	0.00436	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MBD2—bile duct cancer	0.00388	0.00407	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—bile duct cancer	0.00383	0.00402	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—bile duct cancer	0.00365	0.00383	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00365	0.00383	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—bile duct cancer	0.0036	0.00378	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—bile duct cancer	0.0036	0.00377	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00357	0.00374	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—bile duct cancer	0.00337	0.00354	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—bile duct cancer	0.00334	0.00351	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—bile duct cancer	0.0033	0.00347	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—bile duct cancer	0.00329	0.00345	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00324	0.0034	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.00317	0.00332	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.00305	0.0032	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MBD2—bile duct cancer	0.00299	0.00313	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MBD2—bile duct cancer	0.00294	0.00309	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.0029	0.00304	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.00288	0.00302	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00281	0.00295	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00275	0.00288	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—bile duct cancer	0.00274	0.00287	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—bile duct cancer	0.00266	0.00279	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.00258	0.00271	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—bile duct cancer	0.00257	0.00269	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.00256	0.00269	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00253	0.00265	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—bile duct cancer	0.00249	0.00262	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00249	0.00262	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00246	0.00258	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.00239	0.00251	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—bile duct cancer	0.00236	0.00247	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.00235	0.00247	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—bile duct cancer	0.00234	0.00245	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—bile duct cancer	0.00233	0.00244	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00228	0.0024	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.00222	0.00233	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—bile duct cancer	0.00221	0.00232	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00212	0.00223	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—bile duct cancer	0.00201	0.0021	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—bile duct cancer	0.002	0.0021	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—bile duct cancer	0.002	0.00209	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.00199	0.00208	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.00197	0.00207	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00195	0.00204	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—bile duct cancer	0.00192	0.00201	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—bile duct cancer	0.00188	0.00197	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.00184	0.00193	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RNF43—bile duct cancer	0.0018	0.00189	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—bile duct cancer	0.0018	0.00189	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—bile duct cancer	0.00177	0.00186	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00173	0.00182	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—bile duct cancer	0.00165	0.00173	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00164	0.00172	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—bile duct cancer	0.00161	0.00169	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMAD4—bile duct cancer	0.00156	0.00164	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—bile duct cancer	0.00152	0.0016	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—bile duct cancer	0.00135	0.00142	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—bile duct cancer	0.0013	0.00136	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—bile duct cancer	0.00124	0.0013	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMAD4—bile duct cancer	0.0012	0.00126	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMAD4—bile duct cancer	0.00118	0.00124	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFBR2—bile duct cancer	0.000825	0.000865	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNAS—bile duct cancer	0.000796	0.000835	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMAD4—bile duct cancer	0.000781	0.000819	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—bile duct cancer	0.000437	0.000459	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—bile duct cancer	0.000375	0.000393	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—bile duct cancer	0.000332	0.000349	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—bile duct cancer	0.000309	0.000324	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—bile duct cancer	0.000303	0.000318	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—bile duct cancer	0.000286	0.0003	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—bile duct cancer	0.000254	0.000267	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—bile duct cancer	0.000243	0.000255	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—bile duct cancer	0.000233	0.000244	CbGpPWpGaD
